Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients-Reference-Cited by-同舟云学术

Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients

Published:2006-11 Issue:5 Volume:65 Page:626-630
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Fatti Letizia Maria,Scacchi Massimo,Lavezzi Elisabetta,Giraldi Francesca Pecori,De Martin Martina,Toja Paola,Michailidis Georgios,Stramba-Badiale Marco,Cavagnini Francesco

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2006.02639.x/fullpdf

Reference23 articles.

1. Growth hormone and the heart

2. Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study

3. EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION

4. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients

5. ACROMEGALY AND THE HEART: A CLINICAL AND PATHOLOGIC STUDY

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of acromegaly with oral octreotide;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

2. Electrocardiographic Manifestations of Endocrine and Metabolic Disorders;Open Journal of Endocrine and Metabolic Diseases;2023

3. A New Device for Remote Monitoring of Vital Parameters in Acromegalic Patients: Pilot Study;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-12

4. Assessment of Tp-e interval, Tp-e/QT and Tp-e/QTc ratios in patients with acromegaly;Turkish Journal of Medical Sciences;2022-01-01

5. Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series;Asia-Pacific Journal of Clinical Oncology;2021-04-14